NCT02778191 Comparison of Concomitant Cisplatin Versus Carboplatin and 5-fluorouracil With Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma Status COMPLETED Phase N/A
NCT02775435 A Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407) Status COMPLETED Phase PHASE3
NCT02766582 Phase II: Pembrolizumab/Carboplatin/Taxol in Epithelial Ovary Cancer Status COMPLETED Phase PHASE2
NCT02763579 A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) Status COMPLETED Phase PHASE3
NCT02760667 Induction Chemotherapy Followed by Surgery for Locally Advanced Head and Neck Cancer Status UNKNOWN Phase PHASE2
NCT02756130 Birinapant and Carboplatin in Treating Patients and Targeting Recurrent High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (HGSOC) Status WITHDRAWN Phase PHASE1/PHASE2
NCT02756013 Weight-based Dosing for Dense Weekly Paclitaxel and Carboplatin in Overweight Patients w/ Body Surface Area (BSA) > 2.0 Status TERMINATED Phase PHASE2
NCT02755311 Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma Status UNKNOWN Phase PHASE3
NCT02755272 A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02754882 A Study Comparing SB8 and Avastin® in Patients With Advanced Non-squamous Non-small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT02748889 Carboplatin Plus Etoposide With or Without MPDL3280A in Untreated Extensive Stage Small Cell Lung Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT02743923 Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung Cancer Status UNKNOWN Phase PHASE3
NCT02741856 Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation Status UNKNOWN Phase PHASE2/PHASE3
NCT02738346 SCLC on the 2nd Line With Relapsed After Response to Chemotherapy GFPC 01-2013 Status UNKNOWN Phase PHASE3
NCT02735239 Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02735057 Chemoradiotherapy in Elderly Patients With Oesophagus Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT02734524 A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer Status UNKNOWN Phase PHASE2
NCT02734069 Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced NSCLC Status RECRUITING Phase N/A
NCT02730546 Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery Status COMPLETED Phase PHASE1/PHASE2